The POU transcription factor Pit-i activates members of the prolactin/growth hormone gene family in specific endocrine cell types of the pituitary gland. Although Pit-1 is structurally conserved among vertebrate species, evolutionary changes in the pattern of Pit-1 RNA splicing have led to a notable "contraction" of the transactivation domain in the mammalian lineage, relative to Pit-1 in salmonid fish. By site-directed mutagenesis we demonstrate that two splice insertions in salmon Pit-1, called 1 (29 aa) and y (33 aa), are critical for cooperative activation of the salmon prolactin gene. Paradoxically, Pit-i-dependent activation of the prolactin gene in rat is enhanced in the absence of the homologous (3-insert sequence. This apparent divergence in the mechanism of activation of prolactin genes by Pit-1 is target gene specific, as activation of rat and salmon growth hormone genes by The anterior pituitary is composed of unique endocrine cells that regulate growth, reproduction, metabolism, and stress responses in almost all vertebrate species. During embryogenesis in rodents the appearance of these cells is accompanied by the expression of multiple transcription factors, including Pit-1, TEF, LH2, P-Lim/LIM3, Zn-15, and nuclear hormone receptors (reviewed in ref. 1) and more recently identified factors such as T/EBP (2), rpx-1 (3), and gsh-1 (4). The first pituitary factor shown to be critical for the ontogeny of specific cell lineages was Pit-1. Deficiency of Pit-1 in certain dwarf mouse strains precludes the development of mature cell populations producing prolactin, growth hormone, and thyroidstimulating hormone (TSH) (5). In addition to its role in pituitary organogenesis, Pit-1 can directly bind to and activate target genes that encode prolactin, growth hormone, 13 subunit of TSH (TSH13), Pit-1, and growth hormone-releasing hormone receptor (6-10). Pit-1 interactions with DNA-binding sites require a C-terminal POU domain (reviewed in ref. 11), whereas transactivation is dependent on Pit-1 sequences near the N terminus (12).
tin gene in rat is enhanced in the absence of the homologous (3-insert sequence. This apparent divergence in the mechanism of activation of prolactin genes by Pit-1 is target gene specific, as activation of rat and salmon growth hormone genes by Pit The anterior pituitary is composed of unique endocrine cells that regulate growth, reproduction, metabolism, and stress responses in almost all vertebrate species. During embryogenesis in rodents the appearance of these cells is accompanied by the expression of multiple transcription factors, including Pit-1, TEF, LH2, P-Lim/LIM3, Zn-15, and nuclear hormone receptors (reviewed in ref. 1 ) and more recently identified factors such as T/EBP (2) , rpx-1 (3), and gsh-1 (4). The first pituitary factor shown to be critical for the ontogeny of specific cell lineages was Pit-1. Deficiency of Pit-1 in certain dwarf mouse strains precludes the development of mature cell populations producing prolactin, growth hormone, and thyroidstimulating hormone (TSH) (5) . In addition to its role in pituitary organogenesis, Pit-1 can directly bind to and activate target genes that encode prolactin, growth hormone, 13 subunit of TSH (TSH13), Pit-1, and growth hormone-releasing hormone receptor (6) (7) (8) (9) (10) . Pit-1 interactions with DNA-binding sites require a C-terminal POU domain (reviewed in ref. 11 ), whereas transactivation is dependent on Pit-1 sequences near the N terminus (12) .
In mammals, alternative use of RNA splice acceptors in the first pit-1 intron generates Pit-1 isoforms with unique Nterminal transactivation domains (13) (14) (15) (16) . The major isoform, Pit-la, is 291 aa in length and lacks a 26-aa insertion between residues 47 and 48 (called the 13-insert) which is present in the isoform Pit-1,B. A non-abundant isoform expressed in TSHproducing cells, Pit-lT, derives from use of an atypical AT splice acceptor site and contains a 14-aa insert at the same position as the 13-insert (16) . Transient expression studies suggest that Pit-1a and Pit-1,B have differential effects on gene expression. Whereas Pit-la is a strong activator of the rat prolactin and growth hormone promoters (6, 7) , Pit-1l3 is a very weak activator of the prolactin promoter (14, 15) but appears to stimulate growth hormone promoter activity effectively (13) .
Our analysis of pituitary hormone gene expression in the evolutionarily distant vertebrate Oncorhynchus tschawytscha (Chinook salmon) revealed that rat Pit-la is a strong transcriptional activator of the salmon prolactin gene (17) , consistent with a highly conserved mode of activation. Unexpectedly, characterization of Pit-1 clones from a salmon pituitary library failed to identify any Pit-1 cDNAs lacking the 3-insert. Because splicing out of the homologous ,B sequence of rat Pit-1 enhances activation of the rat prolactin gene, we examined whether alternate mechanisms for prolactin gene activation had evolved in salmon and rat lineages. Here we report that activation of the salmon prolactin gene by salmon Pit-1 is potentiated rather than inhibited by the ,3-insert, demonstrating a divergence in the mechanism of activation of a homologous Pit-1 target gene. Importantly, the salmon Pit-1 ,3-insert interacts cooperatively with a second splice insertion in the Pit-1 N-terminal region, for optimal activation of the prolactin gene. This second sequence, called the y-insert, is encoded by apit-1 exon not previously identified in mammalianpit-1 genes. The demonstration that prolactin gene activation in salmon and rat is highly sensitive to the pattern of Pit-1 N-terminal splicing suggests that prolactin genes constrain the evolutionary divergence of the Pit-1 transactivation domain. That growth hormone gene activation is less affected than prolactin gene activation by the insertion or deletion of Pit-1 N-terminal sequences further suggests that constraints are imposed in a target gene-specific manner.
MATERIALS AND METHODS Isolation of 0. tschawytscha Pit-i cDNA and Genomic Clones. A PCR-amplified fragment containing the salmon Pit-1 POU region (17) was labeled with [a-32P]dCTP by the random primer method and used to screen approximately 1 x 106 plaques from a salmon pituitary AZAP (Stratagene) cDNA library. Three identical full-length clones were sequenced on both strands (GenBank accession no. U55045) using Sequenase (Amersham). To define the boundaries of the y-insert (see Fig. 1 ) primers, 5'-CGCAGTGCGCACAGGAGAT-GCTGTC (sense) and 5'-GCCTGCAGCTGCAGTGTGTT-TGCTC (antisense), were used to amplify the 99-bp sequence from a salmon Pit-1 cDNA. After 32p labeling of the PCR product, an EMBL-3 Chinook salmon genomic library (provided by C. Hew, University of Toronto) was screened. A 900-bp SalI/PvuII genomic fragment from a single positive clone was subcloned (Bluescript; Stratagene) and sequenced.
Abbreviation: TSH, thyroid-stimulating hormone. Data deposition: The sequence reported in this paper has been deposited in the GenBank data base (accession no. U55045). *To whom reprint requests should be addressed.
Evolutionary Analysis. The DNA sequence of the Chinook salmon Pit-1 cDNA was aligned manually to Pit-1 sequences of mammals to maximize sequence identity. Divergence at synonymous and nonsynonymous sites was estimated by the method of Nei and Gojobori (18) , as implemented in the computer program MEGA (19) . Divergences were estimated for the entire cDNA sequence (excluding the initiator methionine in all analyses), the N-terminal region (amino acids 2-195 in Fig. 1) , and the POU domain (amino acids 196-341). For comparison, similar analyses were performed on selected sequences for which mammalian and fish (or amphibian) homologues are available, including the POU proteins Oct-1, Brn-1, and Brn-5. Sources of the sequences (with GenBank accession numbers) are as follows: Pit-i-Chinook salmon (this paper), human (X62429), mouse (X57512), and rat (M23253); Oct-1-Xenopus (X17190), human (X13403), and mouse (X56230); Brn-1-zebrafish ZFPou-1 (D13045) and mouse (M88299); and Brn-5-zebrafish pou[c] (X68432), human TCF,B (L14482), mouse Emb (D13801), and rat (L23204).
Site-Directed Loop-out Mutagenesis. Mutagenesis of salmon Pit-1 was performed by using the pSELECT vector (Promega). For mutant DNA strand synthesis an ampicillinase repair primer was used together with mutagenic primers 5' -GTGCAGCCCGGGAGGAC/CTGCGGACACC ((3-insert-specific) and 5 '-CAAGGGGCCAAGGATC/CTGC-CATCATGCCG (,y-insert specific) to delete salmon Pit-1 insert sequences individually or in combination (diagonals in primers indicate junctions of insert-flanking sequences). Mutant clones were identified by the presence of a silent SmaI or a BamHI site introduced by the mutagenic primers and were sequenced.
In 1 mM dithiothreitol, and 0.5 mg of salmon sperm DNA. Bound complexes were resolved on nondenaturing 5% polyacrylamide gels and exposed to Kodak XAR-5 film overnight.
Expression and Reporter Constructs. The simian virus 40-based expression vector for rat Pit-la has been described previously (6) . cDNAs of Pit-1 splice variants and mutants were cloned as XbaI/HindIII fragments into the same vector. The rat prolactin/luciferase reporter has been described (20) . The 2.4-kb salmon prolactin promoter region was excised from salmon PRL CAT (17) (21) was inserted into the luciferase vector after conversion of ends to XhoI (5') and HindIII (3') sites. Luciferase constructs 3xlP and 3xGH1 containing high-affinity Pit-i-binding sites from prolactin and growth hormone genes adjacent to the prolactin minimal promoter (-36 to +34) have been described (22) .
Transient Transfection Assays. Cells were transfected by using calcium phosphate/DNA precipitates as described (17) and harvested for luciferase measurements from the major isoform of rat Pit-1 (Pit-ia). (3-insert is homologous to a 26-residue sequence in the ,B-isoform of rat Pit-1 (13) (14) (15) . In the rat, RNA processing results in the preferential deletion of (3-insert encoding sequences at the 3' end of the first pit-i intron, yielding a 7:1 ratio of Pit-ia to Pit-lof (13) (14) (15) . In salmon, the splice acceptor site required for "a-type" splicing is replaced by a CG dinucleotide, predicting exclusive use of the upstream (3-specific AG ( Fig. 2A) . Analysis of salmon pituitary RNA by reverse transcriptase-PCR revealed only transcripts containing the (3-insert, consistent with the constitutive use of the /3-specific splice acceptor (Fig. 2C ).
The position of the 33-aa insert of salmon Pit-1 (here named the y-insert) was found to coincide with the exon 2/exon 3 junction of mouse Pit-1 (5). We therefore isolated a genomic clone from a salmon library to identify flanking sequences. Consensus splice donor and acceptor sites indicate that the -y-insert is derived from a unique exon (Fig. 2B ), rather than an intron sliding mechanism as in the case of the ,3-insert.
However, similar to the /3-insert, the -y-insert appears to be constitutively spliced into all salmon Pit-1 transcripts (Fig. 2C ), consistent with a functional role in salmonid species. Interest- 
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TSC 000 oaG Aao~asc iAz CCCK SCA SCS CAO OAO a OC COSl aso occ ov ooCA CAC Correctly sized translation products of mutant constructs were expressed in vitro (Fig. 3A) , and they were found to exhibit DNA-binding activities that were comparable to those of wild-type Pit-ls (Fig. 3B) . Moreover, mutant as well as wild-type salmon Pit-ls activated simple Pit-i-dependent promoters efficiently (Fig. 3C) , demonstrating that general transcriptional function was not compromised by insert deletion. The inherently lower activity of rat Pit-1,8 in activation of minimal promoters linked to high-affinity Pit-1 sites is consistent with previous studies showing that the promoters of the prolactin gene (15) and pit-i gene (14) are inefficiently activated by Pit-l,B.
Divergence in the Role of the Pit-13-Insert. The ability of Pit-1 isoforms and N-terminal mutants to activate pituitary members of the prolactin/growth h9rmone gene family was examined by cotransfection of COS-7 cells (Fig. 4 ) and other heterologous cell lines (S.M., unpublished results). We hypothesized that the (3-insert is a negative domain that inhibits Pit-1 activation of certain target genes, including prolactin. Indeed, in comparison to rat Pit-lia or full-length salmon Pit-1, rat Pit-i,3 was found to be a poor activator of the salmon prolactin promoter, as well as the rat prolactin promoter (Fig.  4 A and B) . Furthermore, the promoter of the salmon somatolactin gene, a Pit-i-responsive gene expressed in the neurointermediate lobe of the fish pituitary (26, 27) , was strongly activated by rat Pit-ia or wild-type salmon Pit-1, but not by rat Pit-l,B (Fig. 4C) . In contrast to the weak activation observed with these promoters, growth hormone gene promoters from rat and salmon were efficiently activated by rat Pit-i,3 (Fig. 4 D and E). Because concatemers of the GH1 site from the rat growth hormone gene could not sustain optimal responsiveness to Pit-l,B (Fig. 3C) , our data would suggest that other rrw.:
+t.LProc. Natl. Acad. Sci. USA 93 (1996) Rates are expressed as number of substitutions per site per 109 years ± standard error, and assuming that the fish-mammal, amphibian-mammal, and rodent-primate divergences were 450, 400, and 80 million years ago. Synonymous substitution rates were calculated only between primates and rodents; meaningful rates could not be estimated at greater divergences. NA, not available. Rates of synonymous divergence of all genes are within the range observed for a large number of mammalian genes. *For these comparisons an amphibian (Xenopus) sequence was used.
DNA elements specific to the growth hormone promoter are required for activation by this isoform.
The results with rat Pit-183 suggested that deletion of the homologous 13-insert from salmon Pit-1 should enhance activation of prolactin genes. This prediction was confirmed in the case of the rat prolactin gene, where salmon Pit-1/3P stimulated promoter activity more effectively than the full-length salmon Pit-1 (Fig. 4A) . Unexpectedly, deletion of the salmon Pit-1 13-insert caused a significant 40% reduction in activation of the salmon prolactin promoter (Fig. 4B) , demonstrating that the negative effect of the Pit-1 13-insert on prolactin gene activation is not conserved in the salmonid lineage. Deletion of the salmon Pit-1 13-insert had an even greater impact on the somatolactin promoter, causing an 80% reduction in activation (Fig. 4C) . A small decrease in activation of the salmon growth hormone promoter was observed upon deletion of the salmon Pit-1 13-insert (Fig. 4E) , consistent with the function of the homologous sequence in rat Pit-1p3.
Cooperative Interactions of Pit-i 3-and y-Inserts Are
Target Gene-and Species-Specific. As shown in Fig. 4 B and C, deletion of the 'y-insert from the salmon Pit-1 N-terminal domain also caused a decrease in activation of the salmon prolactin and somatolactin promoters (70% and 60%, respectively). Deletion of this sequence had little effect on the ability of salmon Pit-1 to activate the rat prolactin promoter or salmon and rat growth hormone promoters (Fig. 4 A, D, and E) . Importantly, when 13-and -y-inserts were deleted from salmon Pit-1 in combination, activation of salmon prolactin and somatolactin promoters was essentially abolished; in marked contrast, salmon Pit-lA13Ay remained a strong activator of the rat prolactin promoter, salmon and rat growth hormone promoters (Fig. 4) , and minimal promoters fused to highaffinity Pit-1 sites (Fig. 3C) . These data show that the y-exon of salmon pit-i encodes an interactive motif within the transactivation domain that requires the 13-insert for full activation of specific target genes. Interestingly, each insert of the salmon Pit-1 transactivation domain exhibits target gene specificity independently, such that salmon Pit-lAy is a stronger activator of the salmon somatolactin promoter than is Pit-l13o (Fig. 4C), whereas Pit-lA13 is more effective than Pit-lAy in the case of the salmon prolactin promoter (Fig. 4B) .
DISCUSSION
Coding sequences of developmental transcription factor genes tend to evolve slowly, being highly constrained so as to minimize undesirable changes in the regulation of multiple target genes. The size of target gene networks may vary-likely depending on species (e.g., Drosophila versus human), the spatial distribution of the developmental regulator, the time of onset of its expression, as well as the duration of its expression during embryogenesis. A recent estimate for the number of potential target genes for the Drosophila homeotic gene Ultrabithorax (Ubx) is in the range of 85 to 170 (28) . Because the number of target genes (constraints) is often large and because DNA regulatory sequences can evolve rapidly, phenotypic differences among species could arise from a divergence in the number, or context, of transcription factor binding sites in multiple target genes, rather than through the structural divergence of the transcription factor itself (29) . Selective changes in the pattern of tissue-specific expression [e.g., enzyme crystallins (30) and gonadotropin a-subunit (31) ], or hormone responsiveness [e.g., plasminogen activator (32)] can be attributed to evolution of cis-regulatory mechanisms. Regulatory evolution can be further accelerated by the ability of some transcription factors, including homeodomain proteins, to recognize degenerate elements in target genes, thereby increasing the frequency of establishing novel interactions that ultimately lead to species-specific phenotypes.
Although the structure of Pit-1 is highly conserved among vertebrate species, our study shows that its rate of divergence is more rapid (i.e., less constrained) than those of two other POU proteins ( (B) Electrophoretic mobility shifts using in vitro lysates incubated with a 32P-labeled high-affinity Pit-1 site from the rat prolactin gene (1P, coordinates -62 to -38) . Binding specificity of each Pit-1 species was identical to that of rat Pit-1 isolated from pituitary GH4 cells (not shown). (C) Transactivation of a minimal prolactin promoter (coordinates -36 to +34) fused to three tandem Pit-1 sites from the rat prolactin gene (1P, coordinates -67 to -37) and the rat growth hormone gene (GH1, coordinates -99 to -69). COS-7 cells were transfected as described in the text. Mutant salmon Pit-ls were comparable to wild-type salmon Pit-1 in activation of these luciferase reporter constructs. Each panel represents four independent experiments; error bars indicate SD. target gene network is sufficiently small such that the role of a given target gene within that network is enhanced. While the size of the Pit-1 target gene network is not known, we would suggest that it may be less complex than those of several other POU or homeodomain proteins, on the basis of the restricted pattern of Pit-1 expression in specific pituitary cell types. Interestingly, Pit-1 transcripts have been detected in the nervous system at early developmental stages (33) , but the importance of potential neural target genes in constraining Pit-1 structure is questionable, as primary defects outside the pituitary have not been described in Pit-1 deficiency.
Our data support a model in which the major transactivation domain of Pit-1 is differentially constrained by target genes of the prolactin/growth hormone family. As determined by analysis of promoter function, prolactin gene expression is highly dependent on the splicing pattern of Pit-1 transcripts within transactivating sequences, whereas growth hormone gene expression is less sensitive to similar changes within this region. Hence, efficient activation of the prolactin gene appears to have a significant role in the evolution of splicing in this region of Pit-1. It should be noted that an important role for the rat Pit-1 (3-insert in growth hormone gene activation was proposed previously (13) , on the basis of differential stability of rat Pit-1 a-and f3-isoforms in transfected cells. A second study, however, failed to identify significant differences in the level of expression of these rat Pit-1 isoforms and concluded rather that the absence of the (3-insert is required for efficient activation of the rat prolactin promoter (15) . The use of alternative cell culture systems and transfection protocols may have contributed to these experimental differences. Our study shows that both rat Pit-a and -03 are efficiently synthesized in vitro and can bind equally well to high-affinity Pit-1 sites. Moreover, transfection data from a number of unrelated cell types support the results in COS cells (Fig. 4) constrains the splicing pattern of the Pit-1 transactivation domain in a species-dependent manner.
In addition to the prolactin gene, splicing of salmon Pit-1 may be constrained by the somatolactin gene. Our data show that somatolactin promoter activation is entirely dependent on the retention of ,3-and y-inserts in the salmon Pit-1 transactivation domain. Although the physiological importance of this Pit-1 target gene is still unclear, there is evidence to suggest a regulatory role in reproduction of teleost fish (34, 35) . Efficient Pit-i-dependent expression of somatolactin may therefore be crucial in some vertebrates. However, because a somatolactin homologue has not yet been identified in tetrapod species, the general significance of this target gene in the evolution of Pit-1 remains to be established.
Our analysis of prolactin and growth hormone gene activation demonstrates that alternative RNA splicing is an effective mechanism for the evolution of new species-and target gene-specific functions of thepit-1 gene. It is likely that optimal regulation of other Pit-1 target genes (e.g., TSHI3 and pit-i itself) also requires specific patterns of splicing in the Pit-1 transactivation domain, and may therefore act to constrain the use of certain splice sites in thepit-i gene. For example, the rat Pit-1 isoform Pit-iT appears to selectively activate the TSH,B subunit promoter-a specificity that depends on splicing at an AT dinucleotide acceptor site within the ,B-insert coding sequence. Whether this mechanism is conserved in other vertebrate species is unclear; a potential AT splice acceptor is present in a bird Pit-1 cDNA (23) but not in salmon (Fig. 1,  nucleotides 273 and 274) .
Last, although the mechanism by which prolactin genes constrain splicing of Pit-1 has not been identified, the importance of protein-protein interactions for Pit-1 activation of the prolactin gene (36) (37) (38) (39) (40) (41) (42) would predict that specific interactions at genomic regulatory sequences are involved. As the prolactin gene evolved to achieve late embryonic expression (36) and a reproductive role in rodent species, rather than early expression (43) and an osmoregulatory role in salmonid fish (44) , critical contacts stabilized by Pit-1 (3-and -y-inserts at the prolactin promoter of salmonid species became unnecessary or even disruptive in the case of rodent prolactin genes. Efficient transactivation of prolactin genes in rodents and other mammals may therefore have contributed to preferential use of the a-splice acceptor in the first pit-i intron. In contrast to prolactin gene activation, transactivation of growth hormone genes involves a Pit-i-dependent mechanism that is largely conserved over a period of 450 million years, consistent with a conserved somatotropic role of this gene in vertebrate species. In this regard, analysis of Pit-i-growth hormone gene interactions could be of considerable interest in anomalous vertebrate models (e.g., guinea pig) in which the obligatory somatotropic role of growth hormone has been altered (45).
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